Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Daliresp (roflumilast)
i
Other names:
APTA-2217, B9302-107, BY-217, BYK 20869, IN-ALR 01
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
AbbVie, AstraZeneca, Takeda
Drug class:
PDE4 inhibitor
Related drugs:
‹
ibudilast (0)
ibudilast (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
NRAS Q61
Melanoma
NRAS Q61
Melanoma
cobimetinib + roflumilast
Sensitive: D – Preclinical
cobimetinib + roflumilast
Sensitive
:
D
cobimetinib + roflumilast
Sensitive: D – Preclinical
cobimetinib + roflumilast
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login